Oncology & Cancer

Watch-and-wait OK in low-tumor burden follicular lymphoma

(HealthDay)—An initial watch-and-wait strategy does not have a detrimental effect on the freedom from treatment failure (FFTF) or overall survival rate in selected patients with low-tumor burden follicular lymphoma compared ...

Oncology & Cancer

Many options, good outcomes, for early-stage follicular lymphoma

(Medical Xpress) -- A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient ...

Oncology & Cancer

Study of two sisters sheds light on lymphoma evolution

When a 41-year-old woman was diagnosed with chronic-phase chronic myeloid leukemia, she received a bone marrow transplant and subsequent leukocyte infusion from her sister. These treatments controlled her leukemia, but seven ...

Oncology & Cancer

From genomic data to new cancer drug

New discoveries about follicular lymphoma, a currently intractable form of cancer, highlight the power of functional genomics in cancer gene discovery. A report in the Oct 28th issue of Cell demonstrates how genetic insights ...

Oncology & Cancer

Scientists look to immune system to handle follicular lymphoma

University of Rochester Medical Center researchers found more evidence that T cells going awry in the microenvironment – or the tissue immediately surrounding the tumor – may play a role in the biology of follicular ...

page 5 from 5